Information disclosed stays confidential, with six named exceptions
What the document says“Information disclosed by a pharmacy benefit manager, an affiliate of a pharmacy benefit manager, a PDP sponsor, or a pharmacy under this subsection that is not otherwise publicly available or available for purchase shall not be disclosed by the Secretary or a PDP sponsor receiving the information, except that the Secretary may disclose the information for the following purposes:”
Information disclosed under the new subsection that is not otherwise public or available for purchase may not be released by the Secretary or a sponsor, except as the Secretary finds necessary to carry out part D, or to the Comptroller General, the Director of the Congressional Budget Office, the Executive Director of the Medicare Payment Advisory Commission, the Attorney General for oversight and enforcement, or the Inspector General. Those officials may not report in a way that identifies a specific firm or plan, or that identifies contract prices, rebates or discounts for specific drugs in a way that could identify the parties or the drugs.
What the document actually says“Information disclosed by a pharmacy benefit manager, an affiliate of a pharmacy benefit manager, a PDP sponsor, or a pharmacy under this subsection that is not otherwise publicly available or available for purchase shall not be disclosed by the Secretary or a PDP sponsor receiving the information, except that the Secretary may disclose the information for the following purposes:”
What these firms hand over stays private. The health chief and the plan may not give it out. The list that follows sets out the few exceptions.
The data holds contract prices that firms guard closely. The named offices may see it to do their work. They may not name names in public.
No action is recorded against this proposal. That is not evidence that none has been taken, and nobody has yet read it against the record. See what the tracker does not yet cover.